Initial Rate of BCR::ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia

被引：0

作者：

Branford, Susan ^{[1
,2
,3
]}

机构：

[1] SA Pathol, Ctr Canc Biol, Adelaide, SA 1, Australia

[2] Univ South Australia, Sch Pharm & Med Sci, Adelaide, Australia

[3] Univ Adelaide, Sch Med, Adelaide, Australia

来源：

TURKISH JOURNAL OF HEMATOLOGY | 2022年 / 39卷 / 03期

关键词：

MOLECULAR RESPONSE; CHRONIC PHASE; CML PATIENTS; BCR-ABL1; SURVIVAL;

D O I：

10.4274/tjh.galenos.2022.2022.0247

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：204 / 205

页数：2

共 13 条

[1] Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline [J].

Branford, Susan ;

Yeung, David T. ;

Parker, Wendy T. ;

Roberts, Nicola D. ;

Purins, Leanne ;

Braley, Jodi A. ;

Altamura, Haley K. ;

Yeoman, Alexandra L. ;

Georgievski, Jasmina ;

Jamison, Bronte A. ;

Phillis, Stuart ;

Donaldson, Zoe ;

Leong, Mary ;

Fletcher, Linda ;

Seymour, John F. ;

Grigg, Andrew P. ;

Ross, David M. ;

Hughes, Timothy P. .

BLOOD, 2014, 124 (04) :511-518

[2] Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib [J].

Branford, Susan ;

Kim, Dong-Wook ;

Soverini, Simona ;

Haque, Ariful ;

Shou, Yaping ;

Woodman, Richard C. ;

Kantarjian, Hagop M. ;

Martinelli, Giovanni ;

Radich, Jerald P. ;

Saglio, Giuseppe ;

Hochhaus, Andreas ;

Hughes, Timothy P. ;

Mueller, Martin C. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) :4323-4329

[3] Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of BCR::ABL1 IS Transcript Levels [J].

Ceran, Funda ;

Akinci, Sema ;

Ucar, Mehmet Ali ;

Korkmaz, Gulten ;

Gunduz, Mehmet ;

Cavdarli, Busranur ;

Bakanay, Sule Mine ;

Falay, Mesude ;

Dagdas, Simten ;

Dilek, Imdat ;

Ozet, Gulsum .

TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (03) :196-203

[4] Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib [J].

Hanfstein, B. ;

Shlyakhto, V. ;

Lauseker, M. ;

Hehlmann, R. ;

Saussele, S. ;

Dietz, C. ;

Erben, P. ;

Fabarius, A. ;

Proetel, U. ;

Schnittger, S. ;

Krause, S. W. ;

Schubert, J. ;

Einsele, H. ;

Hanel, M. ;

Dengler, J. ;

Falge, C. ;

Kanz, L. ;

Neubauer, A. ;

Kneba, M. ;

Stegelmann, F. ;

Pfreundschuh, M. ;

Waller, C. F. ;

Spiekermann, K. ;

Baerlocher, G. M. ;

Pfirrmann, M. ;

Hasford, J. ;

Hofmann, W-K ;

Hochhaus, A. ;

Mueller, M. C. .

LEUKEMIA, 2014, 28 (10) :1988-1992

[5] Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) [J].

Hanfstein, B. ;

Mueller, M. C. ;

Hehlmann, R. ;

Erben, P. ;

Lauseker, M. ;

Fabarius, A. ;

Schnittger, S. ;

Haferlach, C. ;

Goehring, G. ;

Proetel, U. ;

Kolb, H-J ;

Krause, S. W. ;

Hofmann, W-K ;

Schubert, J. ;

Einsele, H. ;

Dengler, J. ;

Haenel, M. ;

Falge, C. ;

Kanz, L. ;

Neubauer, A. ;

Kneba, M. ;

Stegelmann, F. ;

Pfreundschuh, M. ;

Waller, C. F. ;

Branford, S. ;

Hughes, T. P. ;

Spiekermann, K. ;

Baerlocher, G. M. ;

Pfirrmann, M. ;

Hasford, J. ;

Saussele, S. ;

Hochhaus, A. .

LEUKEMIA, 2012, 26 (09) :2096-2102

[6] European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia [J].

Hochhaus, A. ;

Baccarani, M. ;

Silver, R. T. ;

Schiffer, C. ;

Apperley, J. F. ;

Cervantes, F. ;

Clark, R. E. ;

Cortes, J. E. ;

Deininger, M. W. ;

Guilhot, F. ;

Hjorth-Hansen, H. ;

Hughes, T. P. ;

Janssen, J. J. W. M. ;

Kantarjian, H. M. ;

Kim, D. W. ;

Larson, R. A. ;

Lipton, J. H. ;

Mahon, F. X. ;

Mayer, J. ;

Nicolini, F. ;

Niederwieser, D. ;

Pane, F. ;

Radich, J. P. ;

Rea, D. ;

Richter, J. ;

Rosti, G. ;

Rousselot, P. ;

Saglio, G. ;

Saussele, S. ;

Soverini, S. ;

Steegmann, J. L. ;

Turkina, A. ;

Zaritskey, A. ;

Hehlmann, R. .

LEUKEMIA, 2020, 34 (04) :966-984

[7] Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended [J].

Huet, Sarah ;

Cony-Makhoul, Pascale ;

Heiblig, Mael ;

Tigaud, Isabelle ;

Gazzo, Sophie ;

Belhabri, Amine ;

Souche, Denis ;

Michallet, Mauricette ;

Magaud, Jean-Pierre ;

Hayette, Sandrine ;

Nicolini, Franck .

PLOS ONE, 2014, 9 (09)

[8] Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value-A Multicenter Study From South India [J].

Karpurmath, Shashidhar, V ;

Seshachalam, Arun ;

Selvaraj, Kalaiselvi ;

Rajamani, Priyadarshini ;

Kumar, Satish ;

Reddy, Neelesh ;

Malipatil, Baswant ;

Sirigeri, Roopa ;

Prasad, Krishna ;

Reddy, Krishna ;

Danthala, Madhav ;

Udupa, Karthik S. ;

Nandennavar, Manjunath ;

Murugesan, Janarthinakani ;

Patil, C. N. ;

Anoop, Parameswaran ;

Jacob, Roshan Koshy ;

Kalashetty, Mallikarjun ;

Rathnam, Krishnakumar ;

Ganapathy, Ramanan .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05) :E205-E211

[9] Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors [J].

Marin, David ;

Ibrahim, Amr R. ;

Lucas, Claire ;

Gerrard, Gareth ;

Wang, Lihui ;

Szydlo, Richard M. ;

Clark, Richard E. ;

Apperley, Jane F. ;

Milojkovic, Dragana ;

Bua, Marco ;

Pavlu, Jiri ;

Paliompeis, Christos ;

Reid, Alistair ;

Rezvani, Katayoun ;

Goldman, John M. ;

Foroni, Letizia .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) :232-238

[10] BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors [J].

Pennisi, Maria Stella ;

Stella, Stefania ;

Vitale, Silvia Rita ;

Puma, Adriana ;

Di Gregorio, Sandra ;

Romano, Chiara ;

Tirro, Elena ;

Massimino, Michele ;

Antolino, Agostino ;

Siragusa, Sergio ;

Mannina, Donato ;

Impera, Stefana ;

Musolino, Caterina ;

Mineo, Giuseppe ;

Martino, Bruno ;

Zammit, Valentina ;

Di Raimondo, Francesco ;

Manzella, Livia ;

Stagno, Fabio ;

Vigneri, Paolo .

FRONTIERS IN ONCOLOGY, 2019, 9

← 1 2 →